DACS
NVS icon

Dymon Asia Capital (Singapore)’s Novartis NVS Stock Holding History

Dymon Asia Capital (Singapore)’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.63M Sell
16,800
-3,200
-16% -$480K 0.11% 104
2026
Q1 		$3.06M Buy
+20,000
New +$3.07M 0.31% 90

Other funds holding NVS

Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
SI
Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

Dymon Asia Capital (Singapore)'s NVS Position: Q2 2026 in Review

Dymon Asia Capital (Singapore) reduced its Novartis (NVS) stake by 16% in Q2 2026, selling an estimated $480K and leaving 16,800 shares worth $2.63M. The position accounts for 0.11% of the portfolio, ranked #104.

Dymon Asia Capital (Singapore) first reported a position in NVS in Q1 2026 and has held it in 2 quarters since. The position peaked at $3.06M in Q1 2026. 792 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Dymon Asia Capital (Singapore) held 16,800 shares of Novartis worth $2.63M as of Q2 2026.
  • Dymon Asia Capital (Singapore) sold 3,200 Novartis shares in Q2 2026, an estimated $480K.
  • Novartis made up 0.11% of Dymon Asia Capital (Singapore)'s portfolio in Q2 2026, its #104 holding.
  • Dymon Asia Capital (Singapore) first reported a position in Novartis in Q1 2026 and has held it in 2 quarters since.
  • Dymon Asia Capital (Singapore)'s Novartis position peaked at $3.06M in Q1 2026.
  • 792 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Dymon Asia Capital (Singapore)'s 13F filing for Q2 2026, filed 23 Jul 2026.